◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 3332

Nanjing Sinolife United Company Limited (3332) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Consumer Defensive · Packaged Foods · DATA UPDATED 2026-08-10

Nanjing Sinolife United Company Limited (3332) operates in the Packaged Foods industry and is headquartered in Nanjing, China with about 513 employees. Its market capitalization is roughly CNY 122 million. In the fiscal year ended 2025-12-31, 3332 reported CNY 773M in revenue and CNY 25M in net income.

Nanjing Sinolife United Company Limited, an investment holding company, engages in the manufacture and sale of nutritional supplements and trading of packaged health food products in the People's Republic of China, Australia, New Zealand, Vietnam, and internationally.

Interactive charts & full statements →

3332 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 773MCNY 748MCNY 564MCNY 275M
Gross ProfitCNY 566MCNY 538MCNY 380MCNY 160M
Operating Income (EBIT)CNY 25MCNY 42MCNY 59M(CNY 12M)
Net IncomeCNY 25MCNY 35MCNY 53M(CNY 14M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3332 Free Cash Flow History

3332 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 604MCNY 506MCNY 505MCNY 437M
Total LiabilitiesCNY 186MCNY 112MCNY 127MCNY 113M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3332 viewer.

Other Companies in Packaged Foods

← 3330All “0-9” companies3333 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.